Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Pure Global Cannabis Inc. (V:PURE)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 418-2095 Lake Shore Blvd W
Tel: N/A
IR: See website
Key People
Chandrakant Panchal
Chairman of the Board
Malay Panchal
Chief Executive Officer, Director
Bhupender Gosain
Chief Financial Officer and Corporate Secretary
Business Overview
Pure Global Cannabis Inc, formerly Royal Sapphire Corp, is a Canada-based company engaged in the alternative medicine sector. The Company's wholly owned subsidiary, PureSinse, is a pharmaceutical-grade Licensed Producer of cannabis that develops new brands and products for consumers in Canada. Pure Global Cannabis Inc's products include dried flower, cannabis oils, soft gels and capsules, seedlings and clones, vape pen cartridges, topical, sublingual strip/spray, transdermal patch, edibles and beverages, as well as wellness products. The Company's strategy is to pursue and align with other local and international cannabis companies that serve both the medical and anticipated adult-use markets.
Financial Overview
For the nine months ended 30 September 2019, Pure Global Cannabis Inc revenues increased from C$0K to C$1.3M. Net loss decreased 55% to C$8.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Management bonus decrease from C$1.7M (expense) to C$0K, Professional fees decrease of 24% to C$397K (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $17.22M as of Sep 30, 2019
Annual revenue (TTM): $1.28M as of Sep 30, 2019
EBITDA (TTM): -$10.54M as of Sep 30, 2019
Net annual income (TTM): -$11.26M as of Sep 30, 2019
Free cash flow (TTM): -$19.43M as of Sep 30, 2019
Net Debt Last Fiscal Year: $10.56M as of Sep 30, 2019
Shares outstanding: 159,210,512 as of Dec 30, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization